Who Owns Cellectis S.A. Stock?
NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 13.35%
- Held by insiders
- 0.00%
- Institutional holders
- 35
- Institutions 13.3%
- Insiders 0.0%
- Public and other 86.7%
Who owns Cellectis S.A. stock?
Institutional investors own about 13.3% of Cellectis S.A.'s shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of CLLS.
The largest institutional holders are B Group, Inc. (4.55%), Long Focus Capital Management, LLC (3.80%) and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (3.60%). Together, the top 10 institutions control 13.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CLLS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CLLS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| B Group, Inc. | 3.28M | 4.55% | 0.0% |
| Long Focus Capital Management, LLC | 2.74M | 3.80% | 0.0% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.60M | 3.60% | -1.8% |
| Blackrock Inc. | 246.41K | 0.34% | +9.3% |
| Nomura Asset Management International Inc | 226.88K | 0.31% | 0.0% |
| Morgan Stanley | 86.37K | 0.12% | +1.1% |
| LPL Financial LLC | 85.59K | 0.12% | +1.4% |
| UBS Group AG | 47.83K | 0.07% | +41.0% |
| BNP Paribas Financial Markets | 37.50K | 0.05% | -6.5% |
| Walleye Partners, LLC | 35.00K | 0.05% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CLLS
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Biotechnology ETF | 246.41K | 0.34% |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 226.88K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.95K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Cellectis S.A.?
B Group, Inc. is the largest institutional shareholder of CLLS, owning 4.55% of shares outstanding (3.28M shares) as of its latest 13F filing.
What percentage of Cellectis S.A. is owned by institutions?
Institutions own about 13.3% of CLLS shares and 13.3% of the public float.
How much of Cellectis S.A. do insiders own?
Insiders, such as officers and directors, own about 0.00% of CLLS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.